Immucell Stock Price on September 24, 2024
| ICCC Stock | USD 5.50 0.27 5.16% |
Below is the normalized historical share price chart for ImmuCell extending back to May 01, 1987. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ImmuCell stands at 5.50, as last reported on the 19th of January, with the highest price reaching 5.50 and the lowest price hitting 4.94 during the day.
If you're considering investing in ImmuCell Stock, it is important to understand the factors that can impact its price. ImmuCell appears to be slightly risky, given 3 months investment horizon. ImmuCell holds Efficiency (Sharpe) Ratio of 0.2, which attests that the entity had a 0.2% return per unit of risk over the last 3 months. By evaluating ImmuCell's technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please utilize ImmuCell's Downside Deviation of 3.95, risk adjusted performance of 0.1628, and Market Risk Adjusted Performance of 2.55 to validate if our risk estimates are consistent with your expectations.
At present, ImmuCell's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 52.9 M, whereas Common Stock Total Equity is forecasted to decline to about 426.5 K. . As of January 19, 2025, Price To Sales Ratio is expected to decline to 1.70. In addition to that, Price Earnings Ratio is expected to decline to -8.19. ImmuCell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of April 1987 | 200 Day MA 4.3568 | 50 Day MA 3.6074 | Beta 0.567 |
ImmuCell |
Sharpe Ratio = 0.1953
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ICCC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.03 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average ImmuCell is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ImmuCell by adding it to a well-diversified portfolio.
Price Book 1.7647 | Enterprise Value Ebitda (21.19) | Price Sales 2.1106 | Shares Float 4.7 M | Wall Street Target Price 14 |
Related Headline
Lipella Pharmaceuticals Headline on 24th of September 2024
Lipella Pharmaceuticals Reports Encouraging Early Tolerabili... by finance.yahoo.com
PITTSBURGH, Sept. 24, 2024 -- Lipella Pharmaceuticals Inc. , a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced an update on its ongoing multi-center Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus . The Company reported that three participants have completed the four-week treatment with LP-310, an oral rinse, with encouraging
ImmuCell Valuation on September 24, 2024
It is possible to determine the worth of ImmuCell on a given historical date. On September 24, 2024 ImmuCell was worth 3.73 at the beginning of the trading date compared to the closed value of 3.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ImmuCell stock. Still, in general, we apply an absolute valuation method to find ImmuCell's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ImmuCell where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ImmuCell's related companies.
| Open | High | Low | Close | Volume | |
| 3.65 | 3.77 | 3.60 | 3.60 | 21,931 | |
09/24/2024 | 3.73 | 3.73 | 3.49 | 3.53 | 12,405 |
| 3.65 | 3.75 | 3.60 | 3.62 | 22,664 |
| Backtest ImmuCell | | | ImmuCell History | | | ImmuCell Valuation | Previous | Next |
ImmuCell Trading Date Momentum on September 24, 2024
| On September 25 2024 ImmuCell was traded for 3.62 at the closing time. The top price for the day was 3.75 and the lowest listed price was 3.60 . The trading volume for the day was 22.7 K. The trading history from September 25, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 2.55% . The trading delta at closing time against the current closing price is 4.82% . |
ImmuCell Fundamentals Correlations and Trends
By evaluating ImmuCell's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ImmuCell's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ImmuCell financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ImmuCell Stock history
ImmuCell investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ImmuCell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ImmuCell will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ImmuCell stock prices may prove useful in developing a viable investing in ImmuCell
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 8.9 M | 9.4 M | |
| Net Loss | -2.2 B | -2.1 B |
ImmuCell Quarterly Net Working Capital |
|
ImmuCell Stock Technical Analysis
ImmuCell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ImmuCell Period Price Range
Low | January 19, 2025
| High |
0.00 | 0.00 |
ImmuCell cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ImmuCell January 19, 2025 Market Strength
Market strength indicators help investors to evaluate how ImmuCell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ImmuCell shares will generate the highest return on investment. By undertsting and applying ImmuCell stock market strength indicators, traders can identify ImmuCell entry and exit signals to maximize returns
ImmuCell Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ImmuCell's price direction in advance. Along with the technical and fundamental analysis of ImmuCell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ImmuCell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1628 | |||
| Jensen Alpha | 0.7178 | |||
| Total Risk Alpha | 0.6302 | |||
| Sortino Ratio | 0.1782 | |||
| Treynor Ratio | 2.54 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ImmuCell Stock analysis
When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |